Torna all'elenco degli studi
A Study of Teclistamab in Combination With Lenalidomide Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation (MajesTEC-4)
CODICE STUDIO
NCT05243797
TIPOLOGIA
Prima linea giovani
NOME SPONSOR
European Myeloma Network
DESCRIZIONE
Trattamento
Experimental: Arm A: Teclistamab-Lenalidomide (Tec-Len)
Active Comparator: Arm B Lenalidomide Alone (Len)
Lenalidomide orally.
FARMACI UTILIZZATI
Lenalidomide, Teclistamab anticorpo bispecifico